Peru - Number of Confirmed Rifampicina Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) Cases
Since 2014, Peru Number of Confirmed Rifampicina Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) Cases was up 5.3% year on year. In 2019, the country was number 29 comparing other countries in Number of Confirmed Rifampicina Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) Cases with 1,894 Cases. Peru is overtaken by Uzbekistan, which was ranked number 28 with 2,060 Cases and is followed by North Korea at 1,528 Cases. India lead the ranking with 66,255 Cases in 2019, that is an increase of 13.6% compared to 2018. India, Russia and Russia respectively ranked number 2, 3 and 4 in this ranking. Republic of the Congo recorded the best 5 years average growth at +171.1% per year, while Croatia recorded the worst performance at -100% per year.
Loading...
| Date | Units (Cases) |
|---|---|
| 2019 | 1,894.00 |
| 2018 | 1,942.00 |
| 2017 | 1,508.00 |
| 2016 | 1,457.00 |
| 2015 | 1,534.00 |
How does Peru rank in Number of Confirmed Rifampicina Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) Cases?
| # | 359 Countries | Units (Cases) | Last | YoY | 5‑years CAGR | ||
|---|---|---|---|---|---|---|---|
| 1 |
#1
India
|
66,255 | 2019 | +13.6 % | +20.8 % | View data | |
| 3 |
#3
Russia
|
29,181 | 2019 | +5.0 % | +13.4 % | View data | |
| 27 |
#27
North Korea
|
2,354 | 2019 | +32.1 % | +64.2 % | View data | |
| 29 |
#29
Peru
|
1,894 | 2019 | -2.5 % | +5.3 % | View data | |
| 31 |
#31
Angola
|
1,523 | 2019 | +134.7 % | +37.8 % | View data | |